...Ho-Jung Kim This study was performed to evaluate the efficacy of various treatment modalities for hyperkalemia in 8 end-stage renal disease (ESRD) patients. Simultaneous administration of sodium bicarbonate and insulin with glucose was compared with infusion of either bicarbonate alone or insulin...

...Sae Yong Hong; Dong Ho Yang Considering that PAI-1 is an important factor modulating the systemic fibrinolytic activity, the abnormal insulin metabolism frequently seen in end-stage renal disease (ESRD) may cause decreased fibrinolytic activity in concert with PAI-1. To study this possibility, we...

... found in renal failure patients inhibits both the insulin-and tolbutamide-stimulated glucose utilization. Its inhibitory activity is partially additive with diltiazem inhibition and nonadditive in the case of magnesium depletion. It is concluded that ψ inhibits glucose utilization at the level of Ca...

...Ivan Contreras; José F. Caro; Laura Aveledo; Keybell Diaz; Pedro Durrego; José R. Weisinger We studied in vivo biochemical effects of insulin in the skeletal muscle of chronically uremic and control rats. The rate of disappearance of blood glucose (determined with a short intravenous test...

... of 75 g glucose was prevented by the concomitant infusion of somatostatin (350 μg/h), but this was accompanied by severe hyperkalemia (7.4 mmol/l). Suppression of insulin by somatostatin may have contributed to the hyperkalemia by impairing cellular potassium uptake. We conclude that although...

...R.A. Mactier; H. Moore; R. Khanna; J. Shah The intraperitoneal route is frequently used for the administration of insulin in diabetic continuous ambulatory peritoneal dialysis patients. However, there is conflicting evidence as to whether the dosage of intraperitoneal insulin should be increased...

...Ewa Żukowska-Szczechowska; Władysław Grzeszczak; Franciszek Kokot; Teresa Nieszporek; Stanisław Kuśmierski; Adam Szkodny In 24 patients with a kidney transplant and in 10 healthy subjects the test meal response of immunoreactive insulin (IRI), glucagon (IR-G), pancreatic polypeptide (IR-PP...

...Munetada Oimomi; Hiroshi Hatanaka; Yukio Yoshimura; Koichi Yokono; Shigeaki Baba; Yoshihisa Taketomi A nonspecific binding reaction between cyanic acid formed from urea and protein or peptide is called carbamylation. In the present study, insulin, a peptide hormone, was subjected to carbamylation...

...Victor W. Armstrong; Werner Creutzfeldt; Reinhold Ebert; Christoph Fuchs; Reinhardt Hilgers; Fritz Scheler The effect of a dialysate exchange with both 1.5 and 4.25% glucose solutions on plasma levels of glucose, insulin, gastric inhibitory polypeptide (GIP), and glucagon has been investigated in 5...

... significant decrease of plasma and muscle potassium concentrations, metabolic alkalosis, reduced plasma insulin, and increased creatine phosphokinase levels. Blood lactate, pyruvate, and oxoglutarate levels were significantly enhanced in fasted KD rats, whereas blood citrate, β-hydroxybutyrate, and glucose...

...C. Loschiavo; A. Lupo; E. Valvo; N. Tessitore; S. Ferrari; A. Corgnati; G. Maschio The effects of a standard oral glucose tolerance test (OGTT) on the serum concentrations of glucose, insulin, growth hormone (GH) and cortisol were evaluated in 38 adult patients with primary nephrotic syndrome...

...Joseph E. Beaumont; Earl D. Rees; Robert G. Luke After infusion of 250 ml of essential L -amino acids, plasma levels of α-amino nitrogen (α-AN 2 ) in six chronic renal failure (CRF) patients were not different from those in six carefully matched control (CON) subjects. Plasma insulin increments...

... to in the content or advertisements. Polypeptide hormones Kidney Uremia Insulin Glucagon Erythropoietin Prolactin Luteinizing hormone Proinsulin C-peptide Metabolism Nephron 22: 69-80 (1978) Metabolism of Polypeptide Hormones by the Normal Kidney and in Uremia Adrian I. Katz and Dimitrios S...

... or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements. Growth Brain development Insulin Proinsulin Somatomedins Nutritional status Bartter’s syndrome Nephron 23: 130-135(1979) Growth Characteristics in Patients with Bartter s...

...S.I. Ryabov; A.D. Kozhevnikov Exogenous insulin sensitivity as well as the dynamics of blood serum levels of immunoreactive insulin and growth hormone (GH) after oral glucose loading were studied in patients with glomerulonephritis of different clinical manifestations and varying renal functions...

...Fumiaki Marumo; Tenei Sakai; Seiya Sato To determine whether glucose intolerance in patients with chronic renal failure could improve by hemodialysis, the effects of arginine infusion on the concentrations of blood sugar, insulin, glucagon, growth hormone were examined in healthy volunteers...

... insulin metabolism. The renal arteriovenous difference is approximately 30–45% and a linear relationship exists between the arterial insulin level and the renal arteriovenous concentration difference. The renal extraction of insulin is 200 ml/min in man, and it is estimated that 6–8 U are removed...

...N. White; S.A. Snowden; V. Parsons; J. Sheldon; M. Bewick Ten diabetics, nine requiring insulin, were kept alive on peritoneal dialysis and haemodialysis for varying periods of time, with a mean suvival rate of 7 months only per patient. The management of the cardiovascular problems affecting...

... can be launched by either a single or combined regimen of the three agents that cause a transcellular shift of potassium – insulin with glucose, β 2 -agonist (albuterol), and NaHCO 3 . As the first choice among these available options, we favor an intravenous bolus of 10 units of insulin with 50 ml...